Deceuninck G - Search Results

1

Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada.

Wals PD, Carbon M, Sévin E, Deceuninck G, Ouakki M. Wals PD, et al. Among authors: deceuninck g. Pediatr Infect Dis J. 2009 Sep;28(9):e271-5. doi: 10.1097/INF.0b013e3181bad212. Pediatr Infect Dis J. 2009. PMID: 19710582

2

Most ten-year-old children with negative or unknown histories of chickenpox are immune.

Boulianne N, Duval B, De Serres G, Deceuninck G, Massé R, Couillard M. Boulianne N, et al. Among authors: deceuninck g. Pediatr Infect Dis J. 2001 Nov;20(11):1087-8. doi: 10.1097/00006454-200111000-00017. Pediatr Infect Dis J. 2001. PMID: 11734718

3

Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.

De Wals P, Deceuninck G, Boulianne N, De Serres G. De Wals P, et al. Among authors: deceuninck g. JAMA. 2004 Nov 24;292(20):2491-4. doi: 10.1001/jama.292.20.2491. JAMA. 2004. PMID: 15562128

4

Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec.

De Wals P, Deceuninck G, De Serres G, Boivin JF, Duval B, Remis R, Massé R. De Wals P, et al. Among authors: deceuninck g. Clin Infect Dis. 2005 Apr 15;40(8):1116-22. doi: 10.1086/428729. Epub 2005 Mar 11. Clin Infect Dis. 2005. PMID: 15791510

5

Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.

De Wals P, Deceuninck G, Boucher RM, Ouakki M. De Wals P, et al. Among authors: deceuninck g. Clin Infect Dis. 2008 Apr 15;46(8):e75-7. doi: 10.1086/533469. Clin Infect Dis. 2008. PMID: 18444843

6

Epidemiology of Guillain-Barré syndrome in the province of Quebec.

Deceuninck G, Boucher RM, De Wals P, Ouakki M. Deceuninck G, et al. Can J Neurol Sci. 2008 Sep;35(4):472-5. doi: 10.1017/s0317167100009136. Can J Neurol Sci. 2008. PMID: 18973064

7

Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: methodological difficulties and imperfect solutions.

De Wals P, Deceuninck G, Ouakki M, Boulianne N, De Serres G, Danzig L. De Wals P, et al. Among authors: deceuninck g. Vaccine. 2009 May 21;27(24):3223-7. doi: 10.1016/j.vaccine.2009.02.055. Epub 2009 Feb 24. Vaccine. 2009. PMID: 19446195

8

Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada.

Deceuninck G, De Wals P, Boulianne N, De Serres G. Deceuninck G, et al. Pediatr Infect Dis J. 2010 Jun;29(6):546-9. doi: 10.1097/INF.0b013e3181cffa2a. Pediatr Infect Dis J. 2010. PMID: 20125062

9

Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programs.

De Wals P, Boulianne N, Sévin E, Ouakki M, Deceuninck G, Guay M. De Wals P, et al. Among authors: deceuninck g. Can J Public Health. 2009 Nov-Dec;100(6):413-6. doi: 10.1007/BF03404335. Can J Public Health. 2009. PMID: 20209732 Free PMC article.

10

Feasibility and impact of providing feedback to vaccinating medical clinics: evaluating a public health intervention.

Brousseau N, Sauvageau C, Ouakki M, Audet D, Kiely M, Couture C, Paré A, Deceuninck G. Brousseau N, et al. Among authors: deceuninck g. BMC Public Health. 2010 Dec 3;10:750. doi: 10.1186/1471-2458-10-750. BMC Public Health. 2010. PMID: 21129216 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters